Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Bone morphogenetic proteins 4 and 7 increase human white and brown adipocyte thermogenic capacity
Kelly T. Long, Cheryl Cero, Sahara L. Ali, Nhuquynh Nguyen, Adrienne R. Guarnieri, Ju Hee Kim, Young Jae Bahn, Jurgen Heymann, Jonathan M. Dreyfuss, Sushil G. Rane, Yu-Hua Tseng, Aaron M. Cypess
Kelly T. Long, Cheryl Cero, Sahara L. Ali, Nhuquynh Nguyen, Adrienne R. Guarnieri, Ju Hee Kim, Young Jae Bahn, Jurgen Heymann, Jonathan M. Dreyfuss, Sushil G. Rane, Yu-Hua Tseng, Aaron M. Cypess
View: Text | PDF
Research Article Endocrinology Metabolism

Bone morphogenetic proteins 4 and 7 increase human white and brown adipocyte thermogenic capacity

  • Text
  • PDF
Abstract

Adipocytes exist along a functional spectrum: white adipocytes are energy storing, and brown adipocytes have thermogenic capacity such that activation may counteract obesity-related disease. In between are UCP1-expressing beige adipocytes, which can transition between these two energetic states. We previously showed that bone morphogenetic protein 7 (BMP7), a member of the TGF-β superfamily, enables differentiation of brown preadipocytes to mature thermogenic cells. To see whether immortalized, clonal human white and brown preadipocytes (hWAs and hBAs, respectively) would become more thermogenic in response to BMP exposure, we treated them with BMP7 or BMP4 for the first 7 days of a 30-day differentiation protocol. In hBAs, absence of either BMP7 or BMP4 led to lower expression of brown-specific markers and oxygen consumption relative to 7 days with either BMP. hWAs treated for 7 days with either BMP did not increase expression of thermogenic protein UCP1 nor induce a brown-like transcription profile. However, BMP-treated hWAs produced adipocytes that had higher basal and drug-induced maximal oxygen consumption, which was UCP1-independent and due substantially to the futile creatine cycle. Our results demonstrate that energetically quiescent hWAs can be pushed into an energy-expending phenotype without transdifferentiation into beige adipocytes, providing a new approach to treat obesity-related metabolic disease.

Authors

Kelly T. Long, Cheryl Cero, Sahara L. Ali, Nhuquynh Nguyen, Adrienne R. Guarnieri, Ju Hee Kim, Young Jae Bahn, Jurgen Heymann, Jonathan M. Dreyfuss, Sushil G. Rane, Yu-Hua Tseng, Aaron M. Cypess

×

Figure 3

BMP4 treatment of 7 days in hBAs and hWAs induces a gene expression pattern similar to BMP7.

Options: View larger image (or click on image) Download as PowerPoint
BMP4 treatment of 7 days in hBAs and hWAs induces a gene expression patt...
qPCR analysis of brown (A–D) and white (F–I) adipocytes at 30 days of differentiation with 7 days of no BMP treatment (dark brown bars), 30 days of differentiation with BMP4 treatment (light brown bars), and 30 days of differentiation with 7 days of BMP7 treatment (checkered dark brown bars). The mRNA expression profiles of (A and F) thermogenic markers, (B and G) white adipocyte markers, (C and H) brown adipocyte markers, and (D and I) beige adipocyte markers (*P < 0.05; **P < 0.01; ****P < 0.0001). (n = 8–24 replicates). Each data point shown represents a biological replicate. (E and J) Immunoblots in hBAs and hWAs, respectively, showing protein levels of OXPHOS proteins and PGC1α. For the hBA blot, the (+) above 7d BMP4 indicates the standard conditions, which is the positive control. In the hWA UCP1 blot, the (*) above rightmost band is the positive control, which was hBAs treated for 7 days with BMP4. Actin used as the loading control. Statistical analysis for qPCR data was conducted using 1-way ANOVA with Benjamini-Hochberg procedure to correct for multiple comparisons.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts